Alpha Profiles · Company Profile

Evommune, Inc.

Canonical company identity and public leadership record.

https://registry.alpha.ac/companies/evommune-inc

Entity: Public listing published
Primary listing: NYSE: EVMN
Verification: Partially verified
Last reviewed: 2026-09-20T04:46:26.469263+00:00

Overview

Alpha's canonical identity and public leadership record for Evommune, Inc..

Canonical AEGIS identity graph

Executive leadership

Current, confirmed roles are shown only when both the person Profile and supporting source record satisfy the public projection boundary. A missing role is not evidence that it does not exist.

Executive team

9 public records

Eugene A. Bauer

Chief Medical Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-166747Apr 21, 2026

Eugene A. Bauer, M.D.

Chief Medical Officer and Director

State: confirmed
Effective: From Apr 21, 2026
Confidence: 94%
Evidence: EVMN DEF 14A executive officersApr 21, 2026

Gregory S. Moss

Chief Business and Legal Officer, Corporate Secretary and Chief Compliance Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-166747Apr 21, 2026

Gregory S. Moss, Esq.

Chief Business and Legal Officer, Corporate Secretary and Chief Compliance Officer

State: confirmed
Effective: From Apr 21, 2026
Confidence: 94%
Evidence: EVMN DEF 14A executive officersApr 21, 2026

Jeegar Patel

Chief Scientific Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-166747Apr 21, 2026

Jeegar Patel, Ph.D.

Chief Scientific Officer

State: confirmed
Effective: From Apr 21, 2026
Confidence: 94%
Evidence: EVMN DEF 14A executive officersApr 21, 2026

Kyle Carver

Chief Financial Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-166747Apr 21, 2026

Kyle Carver, M.B.A., C.P.A.

Chief Financial Officer

State: confirmed
Effective: From Apr 21, 2026
Confidence: 94%
Evidence: EVMN DEF 14A executive officersApr 21, 2026

Luis Peña

President and Chief Executive Officer

State: confirmed
Effective: Date not stated
Confidence: 95%
Evidence: SEC DEF 14A 0001193125-26-166747Apr 21, 2026

Governance leadership

Boards & Committees

Board and committee assignments appear only when the canonical public projection retains a current role and supporting source. Unpublished records are not interpreted as absence.

Record as of Sep 20, 2026. Chair, executive office, Lead Independent Director and committee appointments retain their separate source roles. A complete board composition denominator and committee charters are not established by a partial roster.